RaNA Therapeutics Acquires Shire's Leading mRNA Therapy Platform.

News   Jan 05, 2017 | Original Story From RaNA Therapeutics

 
RaNA Therapeutics Acquires Shire's Leading mRNA Therapy Platform.
 
 
 

RELATED ARTICLES

“Nanokicking” Technology Enables Breakthrough in the Culture of 3D Mineralised Bone Tissue

News

Researchers have grown 3D samples of mineralised bone from human mesenchymal stem cells for the first time without typical osteoinductive media.

READ MORE

The Ancient Behaviour of Sleep, Conserved Throughout Evolution

News

The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.

READ MORE

Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple Sclerosis

News

Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE